UBS Reiterates Buy Rating on Encompass Health Corp (EHC) Following Novo Expansion Plan Announcement
Go back to UBS Reiterates Buy Rating on Encompass Health Corp (EHC) Following Novo Expansion Plan Announcement| 11% CELGENE CORP. ELKS DUE APRIL 06, 2009 (NYSE: EHC) | Delayed: 123.55 -1.28 (1.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $124.83 | 52 Week High | $11.60 | |||
| Open | $125.90 | 52 Week Low | $4.00 | |||
| Day High | $126.10 | P/E | N/A | |||
| Day Low | $123.21 | EPS | $0.00 | |||
| Volume | 549,276 | |||||
